YNG2 Antibody

What is YNG2 and what cellular functions does it regulate?

YNG2 is a subunit of the NuA4 (Nucleosome Acetyltransferase of H4) complex in yeast that plays critical roles in chromatin remodeling through histone H4 acetylation . It is related to the human candidate tumor suppressor Ing1 . YNG2 functions primarily involve DNA replication, repair processes, and cell cycle regulation. Studies have demonstrated that YNG2 mutants (yng2Δ) remain viable but display specific defects in global nucleosomal histone H4 acetylation . These mutants exhibit a characteristic G2/M delay that is dependent on DNA damage checkpoints, suggesting its crucial role in maintaining genomic integrity .

The protein is particularly important for chromatin remodeling processes, with research indicating overlapping roles between H3 and H4 acetylation in DNA replication and repair. This is evidenced by the inviability of gcn5 yng2 double mutants (where GCN5 is a histone H3-specific acetyltransferase), suggesting coordinated histone modifications are essential for cellular function . Understanding YNG2's role provides important insights into how chromatin organization influences genome stability and cellular responses to genotoxic stress.

How is YNG2 involved in DNA damage response?

YNG2 plays a specific and critical role in the response to DNA damage during S-phase of the cell cycle. Research has demonstrated that yng2 mutants are particularly sensitized to DNA damage that occurs during DNA replication, including damage induced by cdc8 or cdc9 mutations, hydroxyurea (HU), camptothecin, and methylmethane sulfonate (MMS) . This specific sensitivity pattern distinguishes YNG2 from typical DNA repair or replication mutants.

When treated with MMS, yng2 mutants display a persistent Mec1-dependent intra-S-phase checkpoint delay characterized by slow DNA repair . Interestingly, restoring H4 acetylation through the application of the histone deacetylase inhibitor trichostatin A promotes checkpoint recovery in these cells . This suggests that YNG2's role in histone H4 acetylation is directly linked to efficient DNA damage repair during S-phase. The spectrum of sensitivities observed in yng2 mutants indicates a specialized function in managing replication-associated DNA damage, rather than a general role in DNA repair or checkpoint activation .

Where is YNG2 protein localized in the cell?

YNG2 has been shown to localize in the nucleus, consistent with its role in chromatin remodeling and DNA-related processes. This localization has been confirmed through GFP-tagging experiments where GFP-tagged YNG2 was expressed in wild-type yeast cells . The expression of this GFP-tagged YNG2 was demonstrated to successfully suppress the yng2Δ phenotypes, indicating that the fusion protein retained its functionality despite the addition of the GFP tag .

The nuclear localization of YNG2 aligns with its identified roles in chromatin remodeling, histone acetylation, and DNA damage response processes. These cellular functions predominantly occur within the nucleus where the chromatin is housed. The specific sub-nuclear distribution pattern of YNG2 can vary depending on cell cycle stage and in response to DNA damage, reflecting its dynamic roles in these processes. This localization information is critical for designing effective experimental approaches, particularly for immunofluorescence studies targeting endogenous YNG2.

What is the relationship between YNG2 and histone acetylation?

YNG2 serves as a critical component of the NuA4 histone acetyltransferase complex that specifically targets histone H4 for acetylation . Mutants lacking YNG2 (yng2Δ) display compromised NuA4 HAT activity both in vitro and in vivo, resulting in a global decrease in histone H4 acetylation levels . This reduction in H4 acetylation leads to phenotypes consistent with defects in DNA metabolism and genomic instability.

Research has shown that there may be overlapping roles between H3 and H4 acetylation in DNA replication and repair processes, as evidenced by the inviability of gcn5 yng2 double mutants . This genetic interaction suggests a coordinated system of histone modifications crucial for maintaining genomic integrity. The relationship between YNG2 and histone acetylation appears particularly important during DNA damage response, as evidenced by the finding that restoring H4 acetylation through histone deacetylase inhibition promotes recovery from DNA damage-induced checkpoint activation in yng2 mutants .

How do I choose the right YNG2 antibody for my experiment?

Selecting the appropriate YNG2 antibody requires careful consideration of several factors including experimental application, epitope specificity, and validation status. Based on principles of antibody design and selection, researchers should evaluate the following criteria:

When working with YNG2, which functions within the NuA4 complex, it's particularly important to consider whether the epitope is accessible when YNG2 is bound to other complex members . For chromatin immunoprecipitation studies, antibodies recognizing epitopes that remain accessible when YNG2 is bound to chromatin are essential for successful experiments . The biophysics-informed modeling approach described in recent research can help predict epitope accessibility in different experimental contexts .

What validation methods should I use for YNG2 antibodies?

Comprehensive validation of YNG2 antibodies is crucial for experimental reliability. Current research emphasizes the importance of multiple validation approaches:

• Genetic controls: Testing antibody specificity using yng2Δ mutant cells as negative controls . This provides the strongest validation by demonstrating absence of signal in knockout specimens.

• Peptide competition assays: Pre-incubating the antibody with the immunizing peptide should abolish specific signals.

• Immunoprecipitation followed by mass spectrometry: This confirms that the antibody captures the intended target with minimal off-target binding.

• Cross-validation with tagged protein: Compare antibody detection with anti-tag antibodies when using GFP-tagged or epitope-tagged YNG2 .

• Western blot analysis: Verification of a single band of the expected molecular weight (approximately 34 kDa for yeast YNG2).

A rigorous validation approach would employ the biophysics-informed modeling discussed in recent research, which can help assess binding specificity profiles and identify potential cross-reactivity issues . This model-based approach is particularly valuable when working with protein families that have conserved domains, as it can help distinguish between specific and non-specific binding modes .

How can I optimize immunoprecipitation with YNG2 antibodies?

Optimizing immunoprecipitation (IP) with YNG2 antibodies requires attention to several key parameters that address the nuclear localization and complex formation properties of YNG2:

• Cell lysis conditions: Since YNG2 is a nuclear protein , use nuclear extraction buffers containing 0.1-0.5% NP-40 or Triton X-100 with 140-420 mM NaCl to balance complex integrity and solubilization.

• Chromatin shearing: For ChIP applications, optimize sonication or enzymatic digestion to generate chromatin fragments of 200-500bp.

• Antibody amount: Titrate antibody concentration (typically 2-5 μg per IP) to find the optimal amount that maximizes signal-to-noise ratio.

• Incubation conditions:

  • Time: Overnight at 4°C for maximal binding

  • Rotation: Gentle rotation to maintain suspension without damaging complexes

• Washing stringency: Increase wash buffer salt concentration gradually (150mM to 500mM NaCl) to determine optimal specificity without losing true interactions.

When studying YNG2 as part of protein complexes like NuA4, consider crosslinking approaches to preserve transient interactions, using either formaldehyde (1%) for protein-DNA interactions or protein crosslinkers for protein-protein interactions . Recent research has demonstrated that optimization of these parameters can significantly improve the detection of specific binding modes while minimizing background signal .

What controls should I include when using YNG2 antibodies?

When designing experiments with YNG2 antibodies, including appropriate controls is essential for accurate result interpretation:

For ChIP experiments with YNG2 antibodies, include additional controls such as regions known to lack YNG2 binding (specificity controls) and regions with established YNG2 occupancy (positive controls). Input normalization is crucial for quantitative comparisons across different experimental conditions or genotypes.

As demonstrated in recent antibody specificity research, controlling for cross-reactivity with closely related epitopes is particularly important when studying protein families with conserved domains . The biophysics-informed model can help identify potential cross-reactivity issues and design appropriate controls .

How can YNG2 antibodies be used in chromatin immunoprecipitation (ChIP) assays?

YNG2 antibodies are valuable tools for ChIP assays to study chromatin binding patterns and histone acetylation activities of the NuA4 complex. Based on research findings about YNG2's role in chromatin remodeling and DNA damage response , the following ChIP protocol optimizations are recommended:

• Crosslinking optimization: Since YNG2 is part of a protein complex (NuA4) that interacts with chromatin, dual crosslinking with 1% formaldehyde (8-10 minutes) followed by a protein crosslinker improves capture efficiency.

• Chromatin preparation:

  • For yeast cells, spheroplasting with zymolyase before sonication improves chromatin accessibility

  • Aim for DNA fragments of 200-300bp for highest resolution

• Antibody selection:

  • Use antibodies validated specifically for ChIP applications

  • Consider N-terminal targeting antibodies, as the C-terminus may be involved in complex formation

• Analysis strategies:

  • Investigate co-occupancy with histone H4 acetylation marks

  • Compare YNG2 binding patterns in response to DNA damage treatments like MMS or HU

  • Examine cell cycle-dependent binding by synchronizing cells

A key application is investigating YNG2 recruitment to DNA damage sites during S-phase, given YNG2's specific role in intra-S-phase DNA damage responses . When designing primers for qPCR analysis following ChIP, focus on origins of replication and known DNA damage-sensitive regions, as YNG2 is implicated in replication-associated DNA damage response.

What are the best protocols for immunofluorescence using YNG2 antibodies?

For successful immunofluorescence (IF) with YNG2 antibodies, consider these optimized procedures based on YNG2's nuclear localization and function:

• Fixation method:

  • Primary option: 4% paraformaldehyde (15 min) preserves protein epitopes

  • For detecting chromatin-bound YNG2: pre-extraction with 0.5% Triton X-100 before fixation removes soluble proteins

• Permeabilization:

  • 0.5% Triton X-100 in PBS (10 minutes) for yeast cells

  • For mammalian cells studying YNG2 orthologs: 0.2% Triton X-100 (5 minutes)

• Blocking:

  • 5% BSA or 10% normal serum (species different from antibody host) for 1 hour

  • Include 0.1% Tween-20 to reduce background

• Antibody incubation:

  • Primary: 1:100 to 1:500 dilution overnight at 4°C

  • Secondary: 1:500 to 1:1000 for 1 hour at room temperature

  • Co-staining with DNA damage markers (e.g., γH2AX) or replication markers to study YNG2's role in DNA damage response

• Counterstaining:

  • DAPI for nuclear visualization

  • Consider co-staining for histone H4 acetylation marks to correlate with YNG2 localization

For studying YNG2's dynamics during DNA damage response, combining IF with techniques like laser micro-irradiation or treatment with DNA damaging agents like MMS can provide valuable insights into recruitment kinetics and interaction with other DNA damage response proteins.

How can I use YNG2 antibodies to study DNA damage response?

YNG2 antibodies are particularly valuable for investigating the role of YNG2 in DNA damage response, especially during S-phase . Based on the research findings, these methodological approaches are recommended:

• Cell synchronization and damage induction:

  • Synchronize cells in G1 with α-factor

  • Release into S-phase with various DNA damaging agents:

    • 0.015-0.03% MMS

    • 0.2M Hydroxyurea

    • UV (100 J/m²)

    • Camptothecin

• Immunoblotting applications:

  • Monitor YNG2 protein levels and post-translational modifications after damage

  • Correlate with histone H4 acetylation status using acetyl-H4 antibodies

  • Track checkpoint activation markers (e.g., Rad53 phosphorylation)

• Chromatin fractionation:

  • Separate soluble and chromatin-bound fractions to assess YNG2 recruitment

  • Compare wild-type vs. damage response mutants

• Co-immunoprecipitation:

  • Identify damage-induced changes in YNG2 interactions with NuA4 complex members

  • Investigate interactions with DNA repair machinery

• ChIP-seq analysis:

  • Map genome-wide YNG2 binding before and after DNA damage

  • Correlate with sites of histone H4 acetylation and DNA damage markers

Research shows that yng2 mutants exhibit a distinctive S-phase checkpoint arrest when challenged with DNA damaging agents , making YNG2 antibodies particularly useful for investigating the relationship between histone acetylation and DNA damage checkpoint activation during replication.

What buffer conditions optimize YNG2 antibody performance?

Buffer optimization is critical for YNG2 antibody performance across different applications. Based on YNG2's nuclear localization and its role in chromatin-associated complexes , consider these optimized buffer conditions:

Important considerations for YNG2 applications:

• Protease inhibitors: Always include complete protease inhibitor cocktail to prevent degradation.

• Chromatin studies: Add 1-2 mM EDTA to inhibit nucleases.

• Cell lysis for nuclear proteins: For efficient extraction of nuclear YNG2, include a nuclear extraction step with 420mM NaCl buffer after initial lysis.

When studying YNG2's role in the intra-S-phase checkpoint , buffer composition becomes particularly important for maintaining phosphorylation status - include both phosphatase inhibitors and deacetylase inhibitors (sodium butyrate, trichostatin A) to preserve post-translational modifications that may regulate YNG2 function during DNA damage response.

How do YNG2 antibodies help distinguish between different phosphorylation states?

YNG2 phosphorylation status may be critical during DNA damage response and cell cycle progression . Phospho-specific YNG2 antibodies provide powerful tools for investigating these modifications:

• Phosphorylation-state specific antibodies:

  • Develop antibodies targeting predicted phosphorylation sites (S/T-Q motifs often phosphorylated by ATM/ATR kinases in response to DNA damage)

  • Validate specificity using phosphatase treatment and phosphomimetic mutants

  • Compare patterns before and after DNA damage treatment

• Methodological approaches:

  • Phos-tag SDS-PAGE: Supplement gels with Phos-tag reagent to separate phosphorylated from non-phosphorylated YNG2 forms

  • 2D gel electrophoresis: Separate based on both isoelectric point and molecular weight

  • Sequential immunoprecipitation: First with general YNG2 antibody, then with phospho-specific antibody

• Validation strategies:

  • Mass spectrometry confirmation of phosphorylation sites

  • In vitro kinase assays to identify responsible kinases

  • Creation of phospho-null mutants (S/T to A) to confirm antibody specificity

Given YNG2's role in the intra-S-phase checkpoint , phosphorylation may regulate its activity in response to replication stress. The Mec1-dependent intra-S-phase checkpoint activation observed in yng2 mutants treated with MMS suggests that YNG2 may be a target of checkpoint kinases, making phospho-specific antibodies particularly valuable for investigating this regulatory relationship .

What are the techniques for studying YNG2 interactions with the NuA4 complex?

Studying YNG2's interactions within the NuA4 complex requires specialized techniques that preserve complex integrity while providing interaction specificity:

• Sequential immunoprecipitation (Co-IP):

  • First IP: Use antibody against another stable NuA4 component

  • Second IP: Use YNG2 antibody to isolate YNG2-containing subcomplexes

  • Analyze complex components by mass spectrometry or western blotting

• Proximity labeling approaches:

  • BioID: Fuse YNG2 with BirA* biotin ligase to biotinylate proximal proteins

  • APEX2: Fuse YNG2 with APEX2 peroxidase for radical-based proximity labeling

  • These methods capture transient interactions that may be missed by Co-IP

• FRET/BRET for live cell interaction studies:

  • Tag YNG2 and potential interaction partners with compatible fluorophores

  • Measure energy transfer as indication of protein proximity

  • Particularly useful for monitoring dynamic changes during DNA damage response

• Cross-linking mass spectrometry (XL-MS):

  • Apply protein crosslinkers to stabilize NuA4 complex

  • Digest and analyze by mass spectrometry to identify crosslinked peptides

  • Provides structural information about complex organization

The biophysics-informed model described in recent research could help identify different binding modes associated with YNG2-protein interactions . This approach could be particularly valuable for studying how YNG2's interactions within the NuA4 complex change during the intra-S-phase checkpoint delay observed in response to DNA damage .

How can YNG2 antibodies be used in multiplexed imaging approaches?

Multiplexed imaging with YNG2 antibodies enables simultaneous visualization of multiple components of DNA damage response and chromatin remodeling pathways:

• Multi-color immunofluorescence:

  • Combine YNG2 antibody with antibodies against:

    • Histone H4 acetylation marks to correlate with YNG2 activity

    • DNA damage markers (γH2AX, 53BP1)

    • Replication proteins (PCNA, RPA)

    • Other NuA4 complex members

  • Use primary antibodies from different species to avoid cross-reactivity

  • Apply spectrally distinct fluorophores to secondary antibodies

• Cyclic immunofluorescence (CycIF):

  • Perform sequential rounds of staining, imaging, and fluorophore inactivation

  • Can achieve 10+ markers on the same sample

  • Particularly valuable for studying complex pathways involving YNG2

• Mass cytometry (CyTOF) for single-cell analysis:

  • Label antibodies with isotopically pure metals

  • Analyze dozens of parameters simultaneously

  • Map YNG2 expression/modification to cell cycle state and damage response

• Spatial transcriptomics with protein detection:

  • Combine YNG2 antibody staining with RNA detection

  • Correlate YNG2 protein localization with gene expression patterns

  • Reveal functional relationships between YNG2-mediated histone acetylation and transcriptional regulation

These multiplexed approaches are particularly valuable for studying YNG2's function in the intra-S-phase checkpoint , enabling simultaneous monitoring of YNG2 localization, histone H4 acetylation status, DNA damage markers, and cell cycle progression in single cells.

What are the challenges in developing specific antibodies for YNG2 orthologs?

Developing specific antibodies for YNG2 orthologs presents several challenges that require advanced strategies to overcome:

• Sequence conservation and specificity issues:

  • YNG2 is related to human ING family proteins

  • Highly conserved regions create cross-reactivity risks

  • Solution: Target less conserved regions or species-specific sequences for immunization

• Structural similarity with related proteins:

  • YNG2 shares structural domains with other ING family proteins

  • Solution: Apply the biophysics-informed modeling approach described in recent research to identify unique epitopes and predict cross-reactivity

• Post-translational modifications affecting epitope recognition:

  • PTMs may mask epitopes or create new ones

  • Solution: Generate modification-specific antibodies or design epitopes that avoid modification sites

• Conformational epitopes vs. linear epitopes:

  • YNG2's function in protein complexes may require conformational epitope recognition

  • Solution: Use full-length protein or properly folded domains for immunization

• Validation challenges across species:

  • Limited availability of knockout controls in some organisms

  • Solution: Use CRISPR/Cas9 to generate knockout cell lines for validation

The antibody design approach described in recent research offers a solution by using biophysics-informed models to predict and generate antibodies with customized specificity profiles . This approach could help develop antibodies that either specifically recognize YNG2 or cross-react with defined subsets of ING family proteins for comparative studies.

How do I address cross-reactivity issues with YNG2 antibodies?

Cross-reactivity challenges with YNG2 antibodies can significantly impact experimental interpretations. Based on antibody design research , here are strategies to address these issues:

• Identify the source of cross-reactivity:

  • Test antibody against recombinant YNG2 and related proteins (ING family)

  • Use yng2Δ mutant cells as negative controls to identify non-specific signals

  • Perform peptide competition assays with both specific and related peptides

• Antibody purification approaches:

  • Affinity purification against the immunizing peptide/protein

  • Negative selection against cross-reactive proteins

  • Apply the biophysics-informed model to predict and eliminate cross-reactivity

• Experimental design modifications:

  • Increase washing stringency (higher salt, detergent concentration)

  • Optimize blocking conditions (5% BSA, 5% milk, or commercial blockers)

  • Pre-absorb antibody with cellular lysates from yng2Δ cells

• Confirmatory approaches:

  • Use multiple antibodies targeting different YNG2 epitopes

  • Complement with tagged YNG2 detection using anti-tag antibodies

  • Apply orthogonal methods (mass spectrometry, genetic analysis)

The recent advances in biophysics-informed antibody modeling demonstrate that different binding modes can be associated with specific ligands, enabling the prediction and generation of antibodies with customized specificity profiles . This approach could be particularly valuable for developing YNG2 antibodies that avoid cross-reactivity with related proteins.

What might cause variable YNG2 antibody binding in different experimental conditions?

Variable YNG2 antibody binding across different conditions can stem from multiple factors related to both the antibody properties and YNG2 biology:

• Cell cycle-dependent variations:

  • YNG2 shows G2/M cell cycle dependence

  • Synchronize cells to standardize measurements

  • Include cell cycle markers when analyzing heterogeneous populations

• DNA damage-induced changes:

  • YNG2's involvement in DNA damage response may alter epitope accessibility

  • Compare binding patterns before and after damage induction

  • Control for damage-induced post-translational modifications

• Epitope masking in protein complexes:

  • YNG2 functions within the NuA4 complex

  • Complex formation may hide antibody epitopes

  • Mild denaturation may improve detection of masked epitopes

• Technical variables affecting binding:

  • Buffer composition (ionic strength, detergents, pH)

  • Fixation methods (crosslinking may mask epitopes)

  • Antigen retrieval effectiveness

The biophysics-informed modeling approach can help predict how different experimental conditions might affect antibody binding by identifying distinct binding modes associated with different conformational states .

How should I interpret conflicting results between different YNG2 antibodies?

Interpreting conflicting results between different YNG2 antibodies requires systematic analysis and validation approaches:

• Epitope mapping and comparison:

  • Identify the exact epitopes recognized by each antibody

  • Determine if epitopes are in domains involved in:

    • Protein-protein interactions within NuA4 complex

    • Chromatin binding regions

    • Domains affected by post-translational modifications

  • Differential accessibility of epitopes may explain discrepancies

• Application-specific validation:

  • An antibody validated for Western blot may fail in ChIP or IF

  • Test each antibody in the specific application where conflicts arise

  • Use multiple positive and negative controls for each application

• Specificity assessment:

  • Test all antibodies against yng2Δ samples

  • Perform peptide competition assays

  • Consider the binding mode analysis approach to characterize binding properties

• Biological interpretation frameworks:

  • Different antibodies may reveal different aspects of YNG2 biology

  • N-terminal vs. C-terminal antibodies may detect different isoforms

  • Modification-sensitive antibodies may reveal regulation mechanisms

When studying YNG2's role in intra-S-phase checkpoint , conflicting antibody results might actually reveal important regulatory mechanisms. For example, one antibody might detect total YNG2 while another might be sensitive to damage-induced modifications or conformational changes, providing complementary information about YNG2 regulation during DNA damage response.

What approaches can resolve technical issues in YNG2 chromatin binding assays?

Resolving technical challenges in YNG2 chromatin binding assays requires optimization strategies targeting each step of these complex protocols:

• Chromatin preparation optimization:

  • Crosslinking: Titrate formaldehyde concentration (0.5-2%) and time (5-20 min)

  • Sonication: Optimize cycles, amplitude, and buffer composition

  • For yeast cells: Add zymolyase treatment before sonication

  • Quality control: Verify fragment size distribution (aim for 200-500bp)

• Antibody performance enhancement:

  • Epitope accessibility: Use multiple antibodies targeting different YNG2 regions

  • Specificity: Include yng2Δ controls and IgG controls

  • Sensitivity: Consider signal amplification methods for low-abundance binding

• Protocol modifications for YNG2-specific challenges:

  • Dual crosslinking: Add protein-protein crosslinkers to preserve NuA4 complex interactions

  • Salt concentration: Titrate from 150-500mM NaCl to optimize specificity

  • Detergent selection: Compare performances of NP-40, Triton X-100, and SDS

  • Blocking agents: Test different blockers (BSA, salmon sperm DNA, etc.)

• Alternative techniques when standard ChIP fails:

  • CUT&RUN or CUT&Tag: Higher sensitivity for difficult targets

  • ChEC-seq: Tethered MNase approach for challenging proteins

  • ChIP-exo or ChIP-nexus: Higher resolution mapping

For studying YNG2's role in DNA damage response , consider performing ChIP at multiple time points after damage induction and include sequential ChIP with other DNA damage response proteins to determine co-occupancy at specific genomic loci.